Global Nausea And Vomiting Treatment Market Overview And Scope:
Global Nausea And Vomiting Treatment Market Size was estimated at USD 5542.68 million in 2022 and is projected to reach USD 8117.22 million by 2028, exhibiting a CAGR of 6.56% during the forecast period.
The Global Nausea And Vomiting Treatment Market Report 2025 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Nausea And Vomiting Treatment utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2025 and 2032. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
Top Key Players Mentioned Are: Merck and Co. Inc., Helsinn Group, Unimed Pharmaceuticals (AbbVie Inc.), Kyowa Kirin, Sanofi, Qilu Pharma, Teva Pharmaceutical Industries Ltd., Taiji group, Novartis, Heron Therapeutics, Atnahs Pharma UK Limited, Mylan, Duchesnay, Tesaro
Global Nausea And Vomiting Treatment Market Segmentation
By Type, Nausea And Vomiting Treatment market has been segmented into:Serotonin Receptor Antagonist
Neurokinin NK1 Receptor Antagonist
Others
By Application, Nausea And Vomiting Treatment market has been segmented into:
CINV
PONV
Motion Sickness
Pregnancy
Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Nausea And Vomiting Treatment market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Nausea And Vomiting Treatment market.
Top Key Players Covered in Nausea And Vomiting Treatment market are:
Merck and Co. Inc.
Helsinn Group
Unimed Pharmaceuticals (AbbVie Inc.)
Kyowa Kirin
Sanofi
Qilu Pharma
Teva Pharmaceutical Industries Ltd.
Taiji group
Novartis
Heron Therapeutics
Atnahs Pharma UK Limited
Mylan
Duchesnay
Tesaro
Objective to buy this Report:
1. Nausea And Vomiting Treatment analysis predicts the representation of this market, supply and demand, capacity, detailed investigations, etc.
2. Even the report, along with the international series, conducts an in-depth study of rules, policies and current policy.
3. In addition, additional factors are mentioned: imports, arrangement of commodity prices for the market, supply and demand of industry products, major manufacturers.
4. The report starts with Nausea And Vomiting Treatment market statistics and moves to important points, with dependent markets categorized by market trend by application.
5. Applications of market may also be assessed based on their performances.
6. Other market attributes, such as future aspects, limitations and growth for all departments.
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Nausea And Vomiting Treatment Market by Type
5.1 Nausea And Vomiting Treatment Market Overview Snapshot and Growth Engine
5.2 Nausea And Vomiting Treatment Market Overview
5.3 Serotonin Receptor Antagonist
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Serotonin Receptor Antagonist: Geographic Segmentation
5.4 Neurokinin NK1 Receptor Antagonist
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Neurokinin NK1 Receptor Antagonist: Geographic Segmentation
5.5 Others
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Others: Geographic Segmentation
Chapter 6: Nausea And Vomiting Treatment Market by Application
6.1 Nausea And Vomiting Treatment Market Overview Snapshot and Growth Engine
6.2 Nausea And Vomiting Treatment Market Overview
6.3 CINV
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 CINV: Geographic Segmentation
6.4 PONV
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 PONV: Geographic Segmentation
6.5 Motion Sickness
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Motion Sickness: Geographic Segmentation
6.6 Pregnancy
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size (2017-2032F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Pregnancy: Geographic Segmentation
6.7 Others
6.7.1 Introduction and Market Overview
6.7.2 Historic and Forecasted Market Size (2017-2032F)
6.7.3 Key Market Trends, Growth Factors and Opportunities
6.7.4 Others: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Nausea And Vomiting Treatment Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Nausea And Vomiting Treatment Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Nausea And Vomiting Treatment Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 MERCK AND CO. INC.
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 HELSINN GROUP
7.4 UNIMED PHARMACEUTICALS (ABBVIE INC.)
7.5 KYOWA KIRIN
7.6 SANOFI
7.7 QILU PHARMA
7.8 TEVA PHARMACEUTICAL INDUSTRIES LTD.
7.9 TAIJI GROUP
7.10 NOVARTIS
7.11 HERON THERAPEUTICS
7.12 ATNAHS PHARMA UK LIMITED
7.13 MYLAN
7.14 DUCHESNAY
7.15 TESARO
Chapter 8: Global Nausea And Vomiting Treatment Market Analysis, Insights and Forecast, 2017-2032
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Serotonin Receptor Antagonist
8.2.2 Neurokinin NK1 Receptor Antagonist
8.2.3 Others
8.3 Historic and Forecasted Market Size By Application
8.3.1 CINV
8.3.2 PONV
8.3.3 Motion Sickness
8.3.4 Pregnancy
8.3.5 Others
Chapter 9: North America Nausea And Vomiting Treatment Market Analysis, Insights and Forecast, 2017-2032
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Serotonin Receptor Antagonist
9.4.2 Neurokinin NK1 Receptor Antagonist
9.4.3 Others
9.5 Historic and Forecasted Market Size By Application
9.5.1 CINV
9.5.2 PONV
9.5.3 Motion Sickness
9.5.4 Pregnancy
9.5.5 Others
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Nausea And Vomiting Treatment Market Analysis, Insights and Forecast, 2017-2032
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Serotonin Receptor Antagonist
10.4.2 Neurokinin NK1 Receptor Antagonist
10.4.3 Others
10.5 Historic and Forecasted Market Size By Application
10.5.1 CINV
10.5.2 PONV
10.5.3 Motion Sickness
10.5.4 Pregnancy
10.5.5 Others
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Nausea And Vomiting Treatment Market Analysis, Insights and Forecast, 2017-2032
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Serotonin Receptor Antagonist
11.4.2 Neurokinin NK1 Receptor Antagonist
11.4.3 Others
11.5 Historic and Forecasted Market Size By Application
11.5.1 CINV
11.5.2 PONV
11.5.3 Motion Sickness
11.5.4 Pregnancy
11.5.5 Others
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Nausea And Vomiting Treatment Market Analysis, Insights and Forecast, 2017-2032
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Serotonin Receptor Antagonist
12.4.2 Neurokinin NK1 Receptor Antagonist
12.4.3 Others
12.5 Historic and Forecasted Market Size By Application
12.5.1 CINV
12.5.2 PONV
12.5.3 Motion Sickness
12.5.4 Pregnancy
12.5.5 Others
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Nausea And Vomiting Treatment Market Analysis, Insights and Forecast, 2017-2032
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Serotonin Receptor Antagonist
13.4.2 Neurokinin NK1 Receptor Antagonist
13.4.3 Others
13.5 Historic and Forecasted Market Size By Application
13.5.1 CINV
13.5.2 PONV
13.5.3 Motion Sickness
13.5.4 Pregnancy
13.5.5 Others
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Nausea And Vomiting Treatment Market Analysis, Insights and Forecast, 2017-2032
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Serotonin Receptor Antagonist
14.4.2 Neurokinin NK1 Receptor Antagonist
14.4.3 Others
14.5 Historic and Forecasted Market Size By Application
14.5.1 CINV
14.5.2 PONV
14.5.3 Motion Sickness
14.5.4 Pregnancy
14.5.5 Others
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Nausea And Vomiting Treatment Scope:
|
Report Data
|
Nausea And Vomiting Treatment Market
|
|
Nausea And Vomiting Treatment Market Size in 2025
|
USD XX million
|
|
Nausea And Vomiting Treatment CAGR 2025 - 2032
|
XX%
|
|
Nausea And Vomiting Treatment Base Year
|
2024
|
|
Nausea And Vomiting Treatment Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Merck and Co. Inc., Helsinn Group, Unimed Pharmaceuticals (AbbVie Inc.), Kyowa Kirin, Sanofi, Qilu Pharma, Teva Pharmaceutical Industries Ltd., Taiji group, Novartis, Heron Therapeutics, Atnahs Pharma UK Limited, Mylan, Duchesnay, Tesaro.
|
|
Key Segments
|
By Type
Serotonin Receptor Antagonist
Neurokinin NK1 Receptor Antagonist
Others
By Applications
CINV
PONV
Motion Sickness
Pregnancy
Others
|
